Differential diagnosis of relapsing polychondritis from asthma by 18-fluoro-2-deoxyglucose positron emission tomography and computed tomography

Mariko Ono; Yuki Maeda; Nobuyuki Koyama; Hiroyuki Nakamura; Kazutetsu Aoshiba

doi:10.1002/ccr3.3933

Differential diagnosis of relapsing polychondritis from asthma by 18-fluoro-2-deoxyglucose positron emission tomography and computed tomography

Clin Case Rep. 2021 Feb 12;9(4):2475-2476. doi: 10.1002/ccr3.3933. eCollection 2021 Apr.

Authors

Mariko Ono^{1

2}, Yuki Maeda¹, Nobuyuki Koyama³, Hiroyuki Nakamura¹, Kazutetsu Aoshiba¹

Affiliations

¹ Department of Respiratory Medicine Tokyo Medical University Ibaraki Medical Center Inashiki Japan.
² Department of Respiratory Medicine Tokyo Medical University Shinjuku-ku Japan.
³ Department of Clinical Oncology Tokyo Medical University Ibaraki Medical Center Inashiki Japan.

Abstract

About a half of all patients with relapsing polychondritis show airway involvement, which is a major cause of morbidity and mortality from this disease. FDG-PET/CT is useful in the differential diagnosis of relapsing polychondritis from asthma.

Keywords: 18‐fluoro‐2‐deoxyglucose positron emission tomography and computed tomography; bronchial asthma; cough; relapsing polychondritis.